Status:
COMPLETED
General Practitioner (GP) Practice Based Pharmacist Input to Medicines Optimisation
Lead Sponsor:
Queen's University, Belfast
Collaborating Sponsors:
Medicines Optimisation Innovation Centre (MOIC)
Association of the British Pharmaceutical Industry (ABPI)
Conditions:
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is a United Kingdom (UK) based multi-centre study which will evaluate the impact of a medication optimisation intervention (delivered in GP practices by pharmacists to patients at risk of me...
Detailed Description
Drug therapy is growing more complex as patients increasingly suffer from a number of co-morbidities. Accordingly, in clinical medicine, a wide range of medication related problems may arise (1). A me...
Eligibility Criteria
Inclusion
- Patients are included in the study if they have any of the following:
- Have had at least 1 unplanned hospital admission or 2 or more accident and emergency department (A\&E) attendances in the previous 12 months.
- Prescribed ≥ 6 regular oral/systemic, long term medicines.
- Has ≥ 2 long-term chronic conditions.
Exclusion
- Patient is residing in a nursing home or a care home.
- Patient is considered unable to give written informed consent e.g. Alzheimer's disease.
- Palliative care patients.
- Patient has had ≥ 4 unplanned admissions to hospital in the previous 6 months.
- Patient is participating in another intervention research project within the practice.
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2019
Estimated Enrollment :
356 Patients enrolled
Trial Details
Trial ID
NCT03241498
Start Date
December 1 2016
End Date
May 31 2019
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northern Health and Social Care Trust
Antrim, Northern Ireland, United Kingdom